3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
28
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumours
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
fludarabine phosphate
16
Peripheral Blood Stem Cell Transplantation
16
Cyclophosphamide
16
Mycophenolic Acid
14
Whole-Body Irradiation
13
Cyclosporine
12
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Etoposide
7
Cyclosporins
7
Melphalan
6
Sirolimus
5
Radiotherapy
5
Cytarabine
5
Filgrastim
4
Cord Blood Stem Cell Transplantation
4
ruxolitinib
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Alemtuzumab
3
thymoglobulin
2
sargramostim
2
Pentostatin
2
Methylprednisolone
2
Flow Cytometry
2
Carmustine
2
Carboplatin
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic-Myeloproliferative Diseases
×
abiraterone
×
Clear all
No trials found.